Trial intelligence / Profile preview

CH-1504 vs Methotrexate in Active Rheumatoid Arthritis

NCT00658047Phase 2Completed

Sponsor
Chelsea Therapeutics International, Ltd.
Start
Apr 2008
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ch-1504 in rheumatoid arthritis (RA), sponsored by Chelsea Therapeutics International, Ltd.. Started Apr 2008; status: completed.

02

Drugs

ch-1504
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NCT00658047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00658047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call